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A single injection of neuraminidase (NA) within the cerebral ventricles (ICV) triggers an acute
neuroinflammation, which is largely solved in two weeks. Neurological complications or behavioral
alterations have been associated to neuroinflammation. While some of these symptoms decline with time
along with inflammation, the possibility of long-term sequelae should be considered. Thus, we aimed to
explore if NA-induced neuroinflammation provokes behavioral or neurological disturbances at medium (2
weeks) and long (10 weeks) term. Rats were ICV injected with NA or saline. A battery of neurological tests
and a behavioral assessment (open field test) were performed 2 and 10 weeks post-ICV. Also, the
inflammatory status was evaluated by immunohistochemistry and qPCR. First, neurological alterations of
the sensorimotor reflexes were not found, suggesting that NA does not cause disturbances in major brain
functions. While the open field test revealed normal locomotor capacity in the animals injected with NA,
however the evaluation of specific behaviors (rearing and rearing with support) pointed out an increased
anxiety state 2 weeks after NA administration, but not at long term (10 weeks). These results were
confirmed by analyzing all the behavioral parameters measured in the open field test by means of a
principal components analysis. Regarding signs of neuroinflammation, an overexpression of some genes
related to inflammation (the receptor TLR4 and the alarmin HMGB1) was found in the hypothalamus of NA
treated rats at 2 weeks post-ICV, but not at 10 weeks. A histological study of brain areas related to
emotions (amygdala) and stress response (hypothalamic PVN) revealed no significant differences in the
number of microglia or astrocytes. Nevertheless, the morphological analysis of microglial cells (a quite
sensitive tool to evaluate microglial activation) demonstrated that, in the amygdala of NA injected rats,
microglia presented a morphology consistent with a slightly activated state (decreased cell area, cell
perimeter, fractal dimension and roughness; increased cell circularity and lacunarity). Such morphological
change, which was evident 2 weeks after NA injection, was virtually reverted 10 weeks post-ICV. A similar
study performed in PVN microglia yielded very subtle morphological changes (mostly not statistically
significant). These results point out that NA injected ICV may cause anxiety in the medium term (while not
affecting other functions like sensorimotor functions or the locomotor capacity), a behavioral alteration
that is transient and that concurs with a mild inflammation, evidenced by the overexpression of certain
genes and, more notably, by the morphological bias of microglial cells located in the amygdala towards an
activated profile.
